Stay updated on RO6958688 in CEA+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the RO6958688 in CEA+ Solid Tumors Clinical Trial page.

Latest updates to the RO6958688 in CEA+ Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe study page is now a 403 Forbidden error page, replacing the usual study details with a simple error view. This indicates restricted access to the study information and navigation options on the page.SummaryDifference19%

- Check9 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates a backend/template update to the page without changes to the trial details or eligibility criteria.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page's Revision tag was updated from v3.6.5 to v3.6.6, indicating a new release of the page content. This change affects only the page's versioning metadata and not the displayed study information.SummaryDifference0.0%

- Check30 days agoChange DetectedA new NIH grant/contract line and a 2024 Front Immunol article citation were added to the Publications section, broadening the study's referenced literature and funding context.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5, indicating a software release update for the Study Details page. The change represents an administrative version bump rather than a modification to the study data.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page version was updated from v3.6.3 to v3.6.4, indicating a minor patch to the study record page (likely formatting or small content fixes).SummaryDifference0.0%

Stay in the know with updates to RO6958688 in CEA+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RO6958688 in CEA+ Solid Tumors Clinical Trial page.